| Covers the needs of International markets with a range of more than 100 dosage forms including Tablets, Capsules, Dry Powder, Suspension and Injectables. Many of the APIs are made in house, thereby providing a competitive edge for both branded and generic formulations. |
| Manufacturing Facilities: |
 |
The facility is located at Khopoli, Raigad District, Maharashtra. |
|
The manufacturing facility has built up area of 11,432 sq. mtrs. on a plot of 8 Acres. |
|
Dedicated manufacturing plants for: |
| |
 Penicillin based Finished Dosage Forms with an annual capacity of 1500 million Capsules, 20 million bottles Dry Syrup and 500 million Tablets. |
| |
 Non-Penicillin based Finished Dosage Forms with an annual capacity of 2000 million Tablets (Uncoated), 1000 million Tablets (Coated) and 500 million Capsules. |
| Formulation Development: |
|
Developing Products/Formulations matching Reference/Innovators products for the regulated markets. |
|
Generating validation documents for quicker Site Variations in critical markets where the lead time for variation approval is longer. |
|
Focus on Newer and Unique dosage forms like, SR Tabs, Mouth Dissolving Tabs as a tool to add value to the current product portfolio. |
|
Developing Amoxy Clauv to give strategic advantage to the current Amoxy customer base. |
|
Formulations / Packaging development initiatives. |
| Accreditations: |
|
Conformation to the Good Manufacturing Practices of International Standards. |
|
Approved by 11 countries including TGA Australia, MCC South Africa. |
|
More than 428 Product approvals in 46 countries including 10 registrations / product approvals (Amlodipine Tabs, Omeprazole Caps, Azithromycin Caps,
Albendazole Tabs, Flucloxacillin, Erythromycin Tabs, Ibuprofen Tabs, Ceftriaxone Inj. & Amoxycillin range) in South Africa. |
| |
